搜索筛选:
搜索耗时0.0910秒,为你在为你在102,285,761篇论文里面共找到 4 篇相符的论文内容
发布年度:
Management of refractory/recurrent myeloid leukemia by salvaged allogeneic hematopoietic stem cell t
[会议论文] 作者：Hong-Xing Liu,Hui-Wang,Chun-Rong Tong,Dao-Pei Lu,Yan-Li Zhao,Min Xiong,Yue Lu,Xing-Yu Cao,De-Yan Liu,Zhi-Jie Wei,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
...
Management of refractory/recurrent myeloid leukemia by salvaged allogeneic hematopoietic stem cell t
[会议论文] 作者：Hong-Xing Liu,Hui-Wang,Chun-Rong Tong,Dao-Pei Lu,Yan-Li Zhao,Min Xiong,Yue Lu,Xing-Yu Cao,De-Yan Liu,Zhi-Jie Wei,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
Objective: The therapeutic effects of refractory/recurrent myeloid leukemia, which was salvaged by allogeneic hematopoietic stem cell transplantation (HSCT), are usually poor, with high relapse rate a...
Successful management of refractory/recurrent myeloid leukemia via salvaged allogeneic hematopoietic
[会议论文] 作者：Hong-Xing Liu,Hui Wang,Chun-Rong Tong,Dao-Pei Lu,Yan-Li Zhao,Min Xiong,Yue Lu,Xing-Yu Cao,De-Yan Liu,Zhi-Jie Wei,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
...
Successful management of refractory/recurrent myeloid leukemia via salvaged allogeneic hematopoietic
[会议论文] 作者：Hong-Xing Liu,Hui Wang,Chun-Rong Tong,Dao-Pei Lu,Yan-Li Zhao,Min Xiong,Yue Lu,Xing-Yu Cao,De-Yan Liu,Zhi-Jie Wei,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
Objective: The clinical outcomes of refractory/recurrent myeloid leukemia salvaged using allogeneic hematopoietic stem cell transplantation (HSCT) are typically poor with high relapse rate and transpl...
相关搜索：
